ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cyxone Submits First Application to Start Rabeximod Clinical Trial americanpharmaceuticalreview
July 08, 2019Cyxone has submitted an application to the Central Ethics Committee (CEC) in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod, which is in development for the treatment of rheumatoid arthritis (RA).
Pharma Sources Insight January 2025
